Intradermal air pouch leukocytosis as an in vivo test for nanoparticles

Jennifer Vandooren,1 Nele Berghmans,1 Chris Dillen,1 Ilse Van Aelst,1 Isabelle Ronsse,1 Liron Limor Israel,2 Ina Rosenberger,3 Jörg Kreuter,3 Jean-Paul Lellouche,2 Shulamit Michaeli,4 Erica Locatelli,5 Mauro Comes Franchini,5 Miren K Aiertza,6 Laura Sánchez-Abella,6 Iraida Loina...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Vandooren J, Berghmans N, Dillen C, Van Aelst I, Ronsse I, Israel LL, Rosenberger I, Kreuter J, Lellouche JP, Michaeli S, Locatelli E, Comes Franchini M, Aiertza MK, Sánchez-Abella L, Loinaz I, Edwards DR, Shenkman L, Opdenakker G
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2013
Materias:
Acceso en línea:https://doaj.org/article/910c25427a3945dab618e02793f369e7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:910c25427a3945dab618e02793f369e7
record_format dspace
spelling oai:doaj.org-article:910c25427a3945dab618e02793f369e72021-12-02T02:31:47ZIntradermal air pouch leukocytosis as an in vivo test for nanoparticles1178-2013https://doaj.org/article/910c25427a3945dab618e02793f369e72013-12-01T00:00:00Zhttp://www.dovepress.com/intradermal-air-pouch-leukocytosis-as-an-in-vivo-test-for-nanoparticle-a15282https://doaj.org/toc/1178-2013 Jennifer Vandooren,1 Nele Berghmans,1 Chris Dillen,1 Ilse Van Aelst,1 Isabelle Ronsse,1 Liron Limor Israel,2 Ina Rosenberger,3 Jörg Kreuter,3 Jean-Paul Lellouche,2 Shulamit Michaeli,4 Erica Locatelli,5 Mauro Comes Franchini,5 Miren K Aiertza,6 Laura Sánchez-Abella,6 Iraida Loinaz,6 Dylan R Edwards,7 Louis Shenkman,8 Ghislain Opdenakker1 1Rega Institute for Medical Research, University of Leuven, Leuven, Belgium; 2Department of Chemistry and Institute of Nanotechnology and Advanced Materials, Bar-Ilan University, Ramat Gan, Tel Aviv, Israel; 3Institut für Pharmazeutische Technologie, Johann Wolfgang Goethe-Universität, Frankfurt, Germany; 4The Mina and Everard Goodman Faculty of Life Sciences and Advanced Materials and Nanotechnology Institute, Bar-Ilan University, Ramat Gan, Tel Aviv, Israel; 5Department of Industrial Chemistry Toso Montanari, University of Bologna, Bologna, Italy; 6New Materials Department, Fundación CIDETEC, San Sebastián, Spain; 7School of Biological Sciences, University of East Anglia, Norwich, UK; 8Tel Aviv University, Ramat Aviv, Tel Aviv, Israel Abstract: The need for test systems for nanoparticle biocompatibility, toxicity, and inflammatory or adaptive immunological responses is paramount. Nanoparticles should be free of microbiological and chemical contaminants, and devoid of toxicity. Nevertheless, in the absence of contamination, these particles may still induce undesired immunological effects in vivo, such as enhanced autoimmunity, hypersensitivity reactions, and fibrosis. Here we show that artificial particles of specific sizes affect immune cell recruitment as tested in a dermal air pouch model in mice. In addition, we demonstrate that the composition of nanoparticles may influence immune cell recruitment in vivo. Aside from biophysical characterizations in terms of hydrodynamic diameter, zeta potential, concentration, and atomic concentration of metals, we show that – after first-line in vitro assays – characterization of cellular and molecular effects by dermal air pouch analysis is straightforward and should be included in the quality control of nanoparticles. We demonstrate this for innate immunological effects such as neutrophil recruitment and the production of immune-modulating matrix metalloproteases such as MMP-9; we propose the use of air pouch leukocytosis analysis as a future standard assay. Keywords: nanoparticles, biocompatibility, toxicity, air pouch, immunologyA Letter to the Editor has been received and published for this article.Vandooren JBerghmans NDillen CVan Aelst IRonsse IIsrael LLRosenberger IKreuter JLellouche JPMichaeli SLocatelli EComes Franchini MAiertza MKSánchez-Abella LLoinaz IEdwards DRShenkman LOpdenakker GDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2013, Iss Issue 1, Pp 4745-4756 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine (General)
R5-920
spellingShingle Medicine (General)
R5-920
Vandooren J
Berghmans N
Dillen C
Van Aelst I
Ronsse I
Israel LL
Rosenberger I
Kreuter J
Lellouche JP
Michaeli S
Locatelli E
Comes Franchini M
Aiertza MK
Sánchez-Abella L
Loinaz I
Edwards DR
Shenkman L
Opdenakker G
Intradermal air pouch leukocytosis as an in vivo test for nanoparticles
description Jennifer Vandooren,1 Nele Berghmans,1 Chris Dillen,1 Ilse Van Aelst,1 Isabelle Ronsse,1 Liron Limor Israel,2 Ina Rosenberger,3 Jörg Kreuter,3 Jean-Paul Lellouche,2 Shulamit Michaeli,4 Erica Locatelli,5 Mauro Comes Franchini,5 Miren K Aiertza,6 Laura Sánchez-Abella,6 Iraida Loinaz,6 Dylan R Edwards,7 Louis Shenkman,8 Ghislain Opdenakker1 1Rega Institute for Medical Research, University of Leuven, Leuven, Belgium; 2Department of Chemistry and Institute of Nanotechnology and Advanced Materials, Bar-Ilan University, Ramat Gan, Tel Aviv, Israel; 3Institut für Pharmazeutische Technologie, Johann Wolfgang Goethe-Universität, Frankfurt, Germany; 4The Mina and Everard Goodman Faculty of Life Sciences and Advanced Materials and Nanotechnology Institute, Bar-Ilan University, Ramat Gan, Tel Aviv, Israel; 5Department of Industrial Chemistry Toso Montanari, University of Bologna, Bologna, Italy; 6New Materials Department, Fundación CIDETEC, San Sebastián, Spain; 7School of Biological Sciences, University of East Anglia, Norwich, UK; 8Tel Aviv University, Ramat Aviv, Tel Aviv, Israel Abstract: The need for test systems for nanoparticle biocompatibility, toxicity, and inflammatory or adaptive immunological responses is paramount. Nanoparticles should be free of microbiological and chemical contaminants, and devoid of toxicity. Nevertheless, in the absence of contamination, these particles may still induce undesired immunological effects in vivo, such as enhanced autoimmunity, hypersensitivity reactions, and fibrosis. Here we show that artificial particles of specific sizes affect immune cell recruitment as tested in a dermal air pouch model in mice. In addition, we demonstrate that the composition of nanoparticles may influence immune cell recruitment in vivo. Aside from biophysical characterizations in terms of hydrodynamic diameter, zeta potential, concentration, and atomic concentration of metals, we show that – after first-line in vitro assays – characterization of cellular and molecular effects by dermal air pouch analysis is straightforward and should be included in the quality control of nanoparticles. We demonstrate this for innate immunological effects such as neutrophil recruitment and the production of immune-modulating matrix metalloproteases such as MMP-9; we propose the use of air pouch leukocytosis analysis as a future standard assay. Keywords: nanoparticles, biocompatibility, toxicity, air pouch, immunologyA Letter to the Editor has been received and published for this article.
format article
author Vandooren J
Berghmans N
Dillen C
Van Aelst I
Ronsse I
Israel LL
Rosenberger I
Kreuter J
Lellouche JP
Michaeli S
Locatelli E
Comes Franchini M
Aiertza MK
Sánchez-Abella L
Loinaz I
Edwards DR
Shenkman L
Opdenakker G
author_facet Vandooren J
Berghmans N
Dillen C
Van Aelst I
Ronsse I
Israel LL
Rosenberger I
Kreuter J
Lellouche JP
Michaeli S
Locatelli E
Comes Franchini M
Aiertza MK
Sánchez-Abella L
Loinaz I
Edwards DR
Shenkman L
Opdenakker G
author_sort Vandooren J
title Intradermal air pouch leukocytosis as an in vivo test for nanoparticles
title_short Intradermal air pouch leukocytosis as an in vivo test for nanoparticles
title_full Intradermal air pouch leukocytosis as an in vivo test for nanoparticles
title_fullStr Intradermal air pouch leukocytosis as an in vivo test for nanoparticles
title_full_unstemmed Intradermal air pouch leukocytosis as an in vivo test for nanoparticles
title_sort intradermal air pouch leukocytosis as an in vivo test for nanoparticles
publisher Dove Medical Press
publishDate 2013
url https://doaj.org/article/910c25427a3945dab618e02793f369e7
work_keys_str_mv AT vandoorenj intradermalairpouchleukocytosisasaninvivotestfornanoparticles
AT berghmansn intradermalairpouchleukocytosisasaninvivotestfornanoparticles
AT dillenc intradermalairpouchleukocytosisasaninvivotestfornanoparticles
AT vanaelsti intradermalairpouchleukocytosisasaninvivotestfornanoparticles
AT ronssei intradermalairpouchleukocytosisasaninvivotestfornanoparticles
AT israelll intradermalairpouchleukocytosisasaninvivotestfornanoparticles
AT rosenbergeri intradermalairpouchleukocytosisasaninvivotestfornanoparticles
AT kreuterj intradermalairpouchleukocytosisasaninvivotestfornanoparticles
AT lellouchejp intradermalairpouchleukocytosisasaninvivotestfornanoparticles
AT michaelis intradermalairpouchleukocytosisasaninvivotestfornanoparticles
AT locatellie intradermalairpouchleukocytosisasaninvivotestfornanoparticles
AT comesfranchinim intradermalairpouchleukocytosisasaninvivotestfornanoparticles
AT aiertzamk intradermalairpouchleukocytosisasaninvivotestfornanoparticles
AT saacutenchezabellal intradermalairpouchleukocytosisasaninvivotestfornanoparticles
AT loinazi intradermalairpouchleukocytosisasaninvivotestfornanoparticles
AT edwardsdr intradermalairpouchleukocytosisasaninvivotestfornanoparticles
AT shenkmanl intradermalairpouchleukocytosisasaninvivotestfornanoparticles
AT opdenakkerg intradermalairpouchleukocytosisasaninvivotestfornanoparticles
_version_ 1718402422814015488